Scribd
Upload
73 views15 pages

Curexpress

The Indian healthcare market is rapidly growing, projected to increase from $40 billion in 2021 to $130 billion by 2030, driven by strong demand, government support, and rising manpower. Key trends include a shift towards lifestyle diseases, expansion into Tier II and III cities, the rise of telemedicine, and increasing adoption of AI in healthcare. Additionally, the ayurvedic products market is expected to reach $16.27 billion by FY28, while the dietary supplements market is projected to grow significantly, highlighting various opportunities within the healthcare sector.

Uploaded by

devjain1303
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
73 views15 pages

Curexpress

The Indian healthcare market is rapidly growing, projected to increase from $40 billion in 2021 to $130 billion by 2030, driven by strong demand, government support, and rising manpower. Key trends include a shift towards lifestyle diseases, expansion into Tier II and III cities, the rise of telemedicine, and increasing adoption of AI in healthcare. Additionally, the ayurvedic products market is expected to reach $16.27 billion by FY28, while the dietary supplements market is projected to grow significantly, highlighting various opportunities within the healthcare sector.

Uploaded by

devjain1303
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

Healthcare(CureXpress)

Advantages in India
 ATTRACTIVE OPPORTUNITIES
 STRONG DEMAND ( jumped from $40 billion in 2021 to an expected $130 billion in 2030,
with projections hitting $450 billion by 2047)
 POLICY AND GOVERNMENT SUPPORT
 RISING MANPOWER

THE HEALTHCARE MARKET FUNCTIONS THROUGH FIVE SEGMENTS

*MEDICAL INSURANCE = Medical insurance market in India is about USD


12.86 billion in 2022

HOW DO INSURANCE COMPANIES MAKE MONEY


Insurance companies base their business models around assuming and diversifying risk. The
essential insurance model involves pooling risk from individual payers and redistributing it across
a larger portfolio. Most insurance companies generate revenue in two ways: Charging premiums
in exchange for insurance coverage, then reinvesting those premiums into other interest-
generating assets. Like all private businesses, insurance companies try to market effectively and
minimize administrative costs.

HEALTHCARE SECTOR GROWTH RATE

PER CAPITA EXPENDITURE GROWTH

Notable trends in the Indian healthcare sector

 Shift from communicable to lifestyle diseases


Most lifestyle diseases are caused by high cholesterol, high blood pressure,
obesity, poor diet and alcohol
 Expansion to Tier II and Tier III cities
To encourage the private sector to establish hospitals in these cities, the
Government has relaxed taxes on these hospitals for the first five years.
 Emergence of telemedicine
the remote delivery of healthcare services over the telecommunications
infrastructure.
.

Telemedicine – let’s make it clear


Live Videoconferencing (Synchronous) – two-way interaction between a patient
and a healthcare provider using audiovisual telecommunications technology.

Store-and-Forward (Asynchronous) – transmission of a patient’s medical


information through an electronic communications system to a care provider
without a real-time interaction.

Remote Patient Monitoring (RPM) – personal health and medical data


collection from an individual outside a medical facility via electronic
communication technologies. The collected data is transmitted to a healthcare
provider (hospitals, clinics, living facilities, etc.) for use in care and related
support.

 Rising adoption of artificial intelligence (AI)


AI expenditure in India is expected to reach US$ 11.78 billion by 2025 and add
US$ 1 trillion to India’s economy by 2035. The AI in Healthcare

Market is projected to grow from $14.6 Billion in 2023 to $102.7 Billion by 2028.

Rising adoption of AI-based applications has enabled people to talk directly to


doctors, and physicians, and get expertise for the best

Treatment

 Introduction of digital vaccine delivery platform

Indian healthcare sector is poised to grow :-

1. GROWING DEMAND
• Rising income and affordability.
• Growing elderly population, changing
disease patterns.
• Rise in medical tourism.
• Better awareness of wellness,
preventive care and diagnosis
2. POLICY SUPPORT
▪ Encouraging policies for FDI in the private sector.
▪ Reduction in customs duty and other taxes on life-saving
equipment.
▪ NRHM allocated US$ 10 billion for healthcare facilities.
▪ National Health Insurance Mission to cover entire population.

AYURVEDA

 The Indian ayurvedic products market was valued at INR 748.5 Billion in
2023
India's Ayurveda product market is projected to reach $16.27 billion or Rs
1.2 trillion by FY28 from $7 billion or Rs 57,450 crore at present, according
to a study.

OPPORTUNITIES IN HEALTHCARE

India’s pharmaceutical market is in transition. Known primarily for


producing and exporting generic drugs to other countries, India’s
pharma market is on the cusp of multiple policy changes and
increasing adoption of technology by healthcare professionals,
particularly doctors, and domestic pharmaceutical brands and
new digital health apps are poised to benefit.

A $50 billion industry in 2023, India’s pharma market is expected


to grow at roughly ~8% compounded annually over the next five
years.

Innovation in pharma tech typically falls into three categories:


research and development (R&D), clinical trials, and sales and
marketing. Today, we see sales and marketing tech as the most
significant current opportunity in India’s pharma tech market,
given the scale of its addressable profit pool and industry shift to
leveraging digital channels for pharmaceutical sales and
marketing.

----------------------------------------------------------------------------------------------------

SEASONAL SECTORAL GROWTH

MAJOR FOCUS:-

 COSMETICS MARKET
 FITNESS SUPLIMENTS
 MEDICINES
MEDICINES

Different types of medicine:-

1. ALLOPATHIC - A system in which medical doctors and


other health care professionals (such as nurses,
pharmacists, and therapists) treat symptoms and
diseases using drugs, radiation, or surgery

2. HOMEOPATHIC - Homeopathy is an alternative medicine


based on the theory of treating 'like with like'.
Homeopathy claims to stimulate healing responses to
diseases by administering substances that mimic the
symptoms of those diseases in healthy people. The
effectiveness of homeopathic preparations is disputed within
medical science
3. AYURVEDIC- The ancient Indian medical system, also
known as Ayurveda, is based on ancient writings that
rely on a “natural” and holistic approach to physical
and mental health

Consumption trend

 MONSOON CAN AFFECT THE REVENUE OF PHARMACY


 Top pharma companies

 50 Most used drugs


 Vitamin D (Drisdol, Calciferol)
 Amoxicillin (Amoxil, Biomox, Polymox)
 Levothyroxine (Synthroid, Euthyrox, Levoxyl, Unithroid)
 Lisinopril (Prinivil, Zestril)
 Ibuprofen (Advil, Motrin)
 Amphetamine/dextroamphetamine (Adderall, Adderall XR)
 Amlodipine (Norvasc)
 Albuterol HFA (Ventolin HFA, Proair HFA, Proventil HFA)
 Prednisone (Deltasone, Rayos, Prednisone Intensol)
 Gabapentin (Neurontin)
 Benzonatate (Tessalon Perles)
 Alprazolam (Xanax)
 Cyclobenzaprine (Fexmid)
 Azithromycin (Zithromax Z-Pak)
 Atorvastatin (Lipitor)
 Cetirizine (Zyrtec)
 Losartan (Cozaar)
 Amoxicillin/clavulanate potassium (Augmentin)
 Cephalexin (Keflex)
 Metformin (Riomet)
 Metoprolol succinate ER (Toprol XL)
 Folic acid (Folvite)
 Hydrochlorothiazide (Microzide)
 Sildenafil citrate (Viagra, Revatio)
 Trazodone (Desyrel, Oleptro)
 Zolpidem tartrate (Ambien)
 Escitalopram oxalate (Lexapro)
 Clonazepam (Klonopin)
 Methylprednisolone (Medrol)
 Tadalafil (Cialis)
 Methocarbamol (Robaxin)
 Fluconazole (Diflucan)
 Sertraline (Zoloft)
 Doxycycline hyclate (Vibramycin, Acticlate, Targadox)
 Furosemide (Lasix)
 Fluoxetine (Prozac)
 Metronidazole (Vandazole, Metrogel, Flagyl)
 Freestyle Libre
 Omeprazole (Prilosec)
 FeroSul (ferrous sulfate)
 Sulfamethoxazole/trimethoprim (Bactrim)
 Phenobarbital (Luminal, Solfoton)
 Armour Thyroid (desiccated thyroid)
 Bromphen/pseudoephedrine/dextromethorphan (Bromfed
DM)
 Metoprolol tartrate (Lopressor)
 Meloxicam (Mobic)
 Pantoprazole sodium (Protonix)
 Lisinopril/hydrochlorothiazide (Zestoretic)
 Estradiol (Estrace, Climara, Minivelle)
 Famotidine (Pepcid, Pepcid AC, Zantac 360)
Most Commonly Prescribed Children’s Medications -
https://www.verywellhealth.com/the-30-most-prescribed-drugs-in-
pediatrics-2633435

Most Common Medication for older adults - https://www.webmd.com/healthy-


aging/common-medications-for-older-adults

AYURVEDIC
12 Powerful Ayurvedic Herbs and Spices with Health Benefits

 Ashwagandha
 Boswellia
 Triphala
 Brahmi
 Cumin
 Turmeric
 Licorice root
 Gotu kola
 Bitter melon
 Cardamom
 Precautions
 Bottom line

COMPANIES INVOLVED IN AYURVEDA


-----------------------------------------------------------------------------------------------
GYM SUPPLIMENTS
Supplements are dietary supplements commonly used by those involved in
bodybuilding, weightlifting, mixed martial arts, and athletics for the purpose of
facilitating an increase in lean body mass.
INDIAN SUPPLIMENTS MARKET SIZE- The India dietary supplements market size
reached INR 157.4 Billion in 2023. Looking forward, IMARC Group expects the
market to reach INR 491.4 Billion by 2032, exhibiting a growth rate (CAGR) of
13.49% during 2024-2032.
Myths about supplements in India
India Whey Protein Companies

 Agropur US

 Glanbia PLC
 Fon Arla Foods Amba

terra Group

 LACTALIS Ingredients

 Titan Biotech

 Charotar Casein Company

 Euroserum

 Proteinwale

 Medisysbiotech Private Limited

WHY PEOPLE ARE AFRAID TO BUY SUPPLEMENTS ?

 Authenticity issue
 Lack of trusted sources to purchase
 Lack of knowledge
 Orthodox mentality

You might also like